pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·5h ago·1 min read
save

Dash Bio raises $30M Series A led by Oak HC/FT

When he first pitched investors on his startup in the fall of 2024, Dave Johnson felt like he was selling an unpopular idea. The typical VC response to his proposed pharma lab services company was: ...

Aug 3, 2026·read at Endpoints ↗

Dave Johnson, Dash Bio co-founder August 3, 2026 07:00 AM EDT FinancingStartups Ex­clu­sive: Dash Bio nets $30M for 'A­ma­zon Web Ser­vices of drug de­vel­op­men­t' Andrew Dunn Senior Biopharma Correspondent When he first pitched in­vestors on his start­up in the fall of 2024, Dave John­son felt like he was sell­ing an un­pop­u­lar idea. The typ­i­cal … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

source

Reporting by Endpoints.

read at Endpoints ↗
89 words · retrieved 4h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 54m agoFDA expands Pluvicto label, making it available to most metastatic prostate cancer patientsEndpoints
  • 1h agoCurium buys radiopharma rival Lantheus for $8B; Sandoz settles price-fixing caseEndpoints
  • 2h agoWork ethic becomes a flashpoint as China's biotech pace quickensEndpoints
  • 4h agoUpdate: Supernus, Indivior to merge and form CNS-focused drugmakerEndpoints
  • 5h agoBioNTech names Sobi's Guido Oelkers as incoming CEOEndpoints